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Abstract
Background: Anxiety and mood disorders have been shown to be the most relevant psychiatric comorbidities
associated with migraine, influencing its clinical course, treatment response, and clinical outcomes. Limited information
is available on how specific anxiety and depression symptoms are related to migraine. Symptoms-based approach, a
current trend in mental health research, may improve our understanding in migraine comorbidity. The purpose of this
study was to analyze how anxiety and depression aspects are related to migraine through a symptom-based approach.
Methods: We studied 782 patients from the general population who completed a self-administered questionnaire
assessing demographics, headache features, anxiety and depression symptoms. A binary logistic regression analyses
were conducted to test the association between all four ratings in GAD-7 (anxiety) and PHQ-9 (depression) scales
subitems as covariates, and migraine vs no headache as the outcome.
Results: The leading Odd Ratios (OR) observed in individuals with migraine relative to those without migraine were
anxiety related, “Not being able to stop or control worrying” on a daily basis [OR (CI 95%)] 49.2 (13.6–178.2), “trouble
relaxing” 25.7 (7.1–92.6), “Feeling nervous, anxious or on edge” on a daily basis 25.4 (6.9–93.8), and “worrying too much
about different things” 24.4 (7.7–77.6). Although the hallmark symptoms of depression are emotional (hopelessness
and sadness), the highest scores found were physical: apetite, fatigue, and poor sleep. Irritability had a significant
increase in migraine risk [OR 3.8 (1.9–7.8) if experienced some days, 7.5 (2.7–20.7) more than half the days, and 22.0
(5.7–84.9) when experienced nearly every day].
Conclusions: Anxiety was more robustly associated with increase in migraine risk than depression. Lack of ability to
properly control worrying and to relax are the most prominent issues in migraine psychiatric comorbidity. Physical
symptoms in depression are more linked to migraine than emotional symptoms. A symptom-based approach helps
clarifying migraine comorbidity and should be replicated in other studies.
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Background
Migraine is known to be a multifactorial disorder, with
genetic, hormonal, environmental, dietary, sleep and
psychological aspects playing a different role in each indi-
vidual [1], it is considered a bio-behavioural disorder [2].
Anxiety and mood disorders have been shown to be
the most relevant psychiatric comorbidities associated
with migraine, influencing disease prevalence, prognosis,
treatment and clinical outcomes [3]. Studies reported
that mood and anxiety disorders are two to ten times
more common in migraineurs than in the general popu-
lation [4]. Furthermore, they are related, both at the
clinical settings [5] and general population [6], to poorer
quality of life [7] and increased suicide risk [8]. In
addition, psychiatric comorbidities are risk factors for
the progression from episodic to chronic migraine [9].
Patients with tension type headache and comorbid
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psychiatric disorders often exhibit affective temperament
dysregulation and suicidal behaviors [10, 11].
Anxiety and mood disorders coexist in the general
population at large and also in headache patients [5].
The hallmark of anxiety is excessive of worry, while in
depression lack of energy, motivation and sadness pre-
vail. Both disorders display significant physical symp-
toms. In anxiety, irritability, concentration problems,
and agitation are common, whereas in depression,
fatigue, concentration, sleep and appetite are included in
the diagnostic definition [12]. Although anxiety and
mood disorders are consolidated as the two main psy-
chological issues related to migraine, limited information
is available on what symptoms or aspects are more rele-
vant. A more detailed study looking into these variables
is necessary.
Our objective was to test the hypothesis that migraine
might be not equally related to anxiety and mood symp-
toms, so we designed a symptom-based approach study,




This was a population-based, cross-sectional study con-
ducted from August to October 2014 in a representative
sample of the Brazilian population and drawn from a
panel maintained by Qualtrics. Participants were invited
by e-mail to complete a self-administered, online survey,
in return for incentives/cash honorarium (as established
a priori within the panels’ agreements). As surveys were
being completed, response patterns were monitored
against established quotas and made decisions about
sampling in order to meet them. Quotas have been set
in order to limit the respondents according to social
class distribution, age, gender, geographic location so the
population surveyed could meet the same profile of the
general adult population in Brazil, according to the 2010
census.
Security checks and quality verifications were used on
all sources before respondents had begun the survey.
Participants were included if they had online access to
the Internet and were excluded if their email was no
longer valid, if they did not answered or incomplete an-
swered the questionnaire or if they did not accept the
consent term. Quality checks questions and attention
filters were added. Questions were divided into five
blocks randomized so the impact of tiredness of respon-
dents affected equally all questions. Force response
validation was included in all questions. The length of
interview was less than 30 min.
In order to evaluate how much the online population
would differ from a general population, the same ques-
tionnaire was completed by a door-to-door population
of 201 randomly assigned individuals in the city of São
Paulo (Brazil). No differences between groups were
found in education (p = 0.793), income (p = 0.078), BMI
(p = 0.662) and gender (p = 0.313), but age in the online
sample was younger (34.5 vs. 39.8, p < 0.001). All partici-
pants provided written consent. The protocol was ap-
proved by the Albert Einstein Hospital ethics committee.
Instruments
Respondents were asked to complete a self-administered
questionnaire assessing the following sociodemographics:
gender, age, family income, self-reported weight and
height, marital status and education. They were also asked
about symptoms necessary to assign a migraine diagnoses
as per the International Classification of Headache Disor-
ders, second edition (ICHD-2) criteria [13].
Anxiety was assessed with the “General Anxiety
Disorder-7” (GAD-7) scale; while depression was esti-
mated with the “Patient Health Questionnaire-9” (PHQ-9)
scale. Data on religiousness, optimism, life satisfaction,
and happiness were analyzed elsewhere.
Anxiety
GAD-7 [14] is a questionnaire designed to assess anxiety
symptoms, patients are invited to respond to 7 questions
assessing a two-weeks period. Questions are : A) Feeling
nervous, anxious or on edge; B) Not being able to stop
or control worrying; worrying too much about different
things; C) Trouble relaxing; D) Being so restless that is
hard to sit still, E) becoming easily annoyed or irritable, F)
Feeling afraid as if something awful might happen. Four
alternatives are offered: 1. Not at all, 2. Several days, 3.
More than half the days, and 4. Nearly every day. Scores
can range from 0 to 21. The scale has been validated to
portuguese [15].
Depression
The PHQ-9 is a 9-item scoring scale designed and
validated for diagnosis and grading depression based on
DSM-IV criteria, including the following aspects : (1)
anhedonia; (2) depressed mood; (3) trouble sleeping; (4)
feeling tired; (5) change in appetite; (6) guilt, self-blame,
or worthlessness; (7) trouble concentrating; (8) feeling
slowed down or restless; and (9) thoughts of being better
off dead or hurting oneself [16]. Symptoms are rated using
a 4-point scale (0 - never; 1 – several days; 2 - more than
half the time; and 3 - nearly every day) regarding the past
two weeks experienced. The overall scores ranged from 0
to 27. Validation to portugueses is available [17].
Participants were not tested for psychiatric conditions
and data regarding psychoactive substances were not
collected.
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Statistical analysis
Sample size calculation was done based on previous
studies, we estimated a difference in 10% between mi-
graine and controls in anxiety and depression symptoms,
with a 5% significancy and power of 80%, a target of 209
patients were necessary.
Binary logistic regression was applied [18]. Covariates
were items in GAD-7 and PHQ-9 scales, and outcome
was migraine vs no headache in the past year, never
reporting migraine in life. Control group had no symp-
toms of headache, and was free from any reported com-
plicating medical or psychiatric conditions. Only the
online population was used in the analysis.
Univariate binary logistic regression analyses were
conducted to test the association between each covariate
and the outcome [19]. All four ratings in GAD-7 and
PHQ-9 subitems were analyzed as covariates. Sociode-
mographic variables were included and the results ad-
justed accordingly. The assumption of linearity in the
logit scale (log-odds) between each quantitative covariate
and the outcome in binary logistic regression analysis
was assessed by examination of smoothed scatter plots.
A multiple test correction with Bonferroni procedure
was performed. The software R (R Foundation for Statis-
tical Computing, Vienna, Austria) [20] was used for
statistical analyses. A p-value of <0.05 was considered to
be statistically significant, and all reported p-values were
two-sided.
Results
From 967 participants reached, 782 (80.8%) completed
the questionnaire. The main reason for uncompleted
responses was availability of less than 70% of valid or
finished answers. Participants were women in 51.0%,
mean age of 34.4years (SD: 11.3), married (51.5%), with
university level education – completed or in course
(50.6%) and with an income of more than US$400.00
(65.8%). 213 patients fit diagnostic criteria for migraine.
Table 1 describes migraine characteristics. Tables 2 and
3 shows odds ratios and confidence intervals for GAD-7
and PHQ-9 subitems as covariates in univariate logistic
regression 1 is the compared aspect wich is none in the
aspect, 2 is some, 3 is moderate, 4 is severe. Binary out-
comes migraine versus no pain controls. Figure 1 shows
GAD-7 and PHQ-9 subitens ORs with ratings 4, 3, 2
versus 1 (none).
All anxiety and depression items were significantly re-
lated to migraine compared to non-headache controls
(p < 0.05), with the exception of death thoughts at the
two higher ratings.
When looking at anxiety and depression symptoms
and their relation to migraine, odds ratio are much
higher for anxiety symptoms than for depressive symp-
toms (Table 2). Anxiety items had increasingly higher
odds, meanignn that the higher the score, the higher the
odds for migraine. This was not seen for the majority
of depression symptoms. The leading ORs observed
were anxiety related, “Not being able to stop or con-
trol worrying” on a daily basis [OR (CI 95%)] 49.2
(13.6–178.2), “trouble relaxing” 25.7 (7.1–92.6), “Feel-
ing nervous, anxious or on edge” on a daily basis
25.4 (6.8–93.8), and “worrying too much about differ-
ent things” 24.4 (7.6–77.6).
Depressive symptoms scored the highest odds were
physical symptoms, first “poor appetite or overeating”
[OR (CI 95%)] 6.74 (3.2–14.3) for some days, 9.6 (3.8–
24.4) when experienced more than half the days, and
23.3 (6.8–79.2) when experienced nearly every day.
“Feeling tired or having little energy was 9.30 (3.8–22.6),
19.7 (6.6–59.0), and 20.8 (6.2–70.1); “trouble falling or
staying asleep or sleeping too much” 5.9 (2.9–11.9), 3.5
(1.3–9.4), 16.2 (5.4–48.8).
Table 1 Migraine patients demographics and clinical characteristics
Migraine
Demographics N = 213
Age, Mean (SD), y 34.2 (6.3)
















Frequency, Mean (SD) 6.5 (3.7)
Frequency > = 15 days/month (%) 18
History, Mean (SD), years 21.1 (8.2)
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Discussion
The results presented in this paper provide information
on the relation between anxiety, depression and mi-
graine. It shows higher odds in anxiety than depression,
and found some inner aspects of anxiety and depression
more important than others. Previously published articles
showed significant implication of depression and anxiety
in migraine, but which aspects, domains or symptoms are
more relevant have not been studied in great detail. A re-
cent study focused on affective disorders symptoms in
migraineurs [3] analysing patients from different Dutch
databases, LUMINA (migraine) and NESDA (depression
and anxiety), using the Mood and Anxiety Questionnaire
(MASQ-30) to assess three dimensions —lack of positive
affect (depression specific); negative affect (nonspecific);
and somatic arousal (anxiety specific), the later being the
most important.
Table 2 Univariate logistic regression for depression (PHQ-9)











1 61 - -
2 115 6.42 (3.12–13.20) <.001
3 23 5.74 (2.03–16.21) <.001
4 14 13.54 (3.29–55.79) <.001
Feeling down,
depressed, or hopeless
1 75 - -
2 97 3.03 (1.61–5.69) <.001
3 24 8.07 (2.69–24.21) <.001




1 72 - -
2 88 5.95 (2.96–11.95) <.001
3 23 3.53 (1.32–9.43) 0.012
4 30 16.17 (5.37–48.76) <.001
Feeling tired or having
little energy
1 53 - -
2 99 9.30 (3.82–22.64) <.001
3 36 19.71 (6.59–58.99) <.001
4 25 20.81 (6.18–70.09) <.001
Poor appetite or
overeating
1 68 - -
2 83 6.74 (3.19–14.26) <.001
3 36 9.61 (3.79–24.41) <.001
4 26 23.26 (6.83–79.17) <.001
Feeling bad about
yourself
1 95 - -
2 71 7.05 (3.52–14.09) <.001
3 26 2.79 (1.15–6.79) 0.023
4 21 7.66 (2.56–22.93) <.001
Trouble concentrating 1 92 - -
2 74 5.77 (2.94–11.30) <.001
3 27 3.32 (1.37–8.07) 0.008
4 20 5.33 (1.86–15.31) 0.002
Moving or speaking
slowly Or restless
1 114 - -
2 57 4.03 (2.04–7.99) <.001
3 27 2.91 (1.22–6.95) 0.016
4 15 6.86 (1.83–25.70) 0.004
Death thoughts 1 153 - -
2 31 2.82 (1.22–6.53) 0.015
3 19 1.59 (0.61–4.17) 0.347
4 10 2.69 (0.67–10.81) 0.162
Table 3 Univariate logistic regression for anxiety (GAD-7)










1 36 - -
2 114 2.73 (1.15–6.52) 0.023
3 30 14.00 (4.26–46.05) <.001
4 33 25.37 (6.86–93.83) <.001
Not being able to stop
or control worrying
1 71 - -
2 85 16.03 (6.76–38.02) <.001
3 28 23.62 (7.65–73.00) <.001
4 29 49.22 (13.60–178.18) <.001
Worrying too much about
different things
1 59 - -
2 91 12.45 (5.08–30.51) <.001
3 33 19.81 (6.60–59.50) <.001
4 30 24.41 (7.68–77.62) <.001
Trouble relaxing 1 46 - -
2 111 4.04 (1.78–9.15) <.001
3 27 18.09 (5.37–60.90) <.001
4 29 25.69 (7.13–92.64) <.001
Being so restless that is
hard to sit still
1 98 - -
2 68 4.31 (2.23–8.35) <.001
3 26 2.81 (1.16–6.82) 0.022
4 21 12.37 (3.39–45.06) <.001
Becoming easily annoyed
or irritable
1 58 - -
2 104 3.81 (1.87–7.79) <.001
3 27 7.46 (2.69–20.74) <.001
4 24 22.00 (5.70–84.95) <.001
Feeling afraid as if
something awful migth
happen
1 99 - -
2 69 4.11 (2.14–7.90) <.001
3 26 4.94 (1.94–12.57) <.001
4 19 18.65 (4.06–85.72) <.001
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Specific aspects or symptoms in depression and/or
anxiety may be more relevant for migraineurs, being
more sensitive than non-migraine headache sufferers, or
non-headache pain, or non-pain individuals in develop-
ing a certain clinical psychopathological presentation.
Our data supports the idea of anxiety being more impli-
cated to migraine than depression.
When analyzing sub-items utilizing the first rating
(not at all) versus the second possible rating or the first
positive rating (some days) as covariables, (Tables 2 and 3),
even mild symptomatology were significantly related to
migraine with the exception of thoughts about dying.
One may consider not only a GAD DSM diagnosis,
but a trait, or a minimal amount of worry, inability to con-
trol anxiety symptoms, feeling afraid, nervous, or anxious
can play a critical role in migraine, by triggering an attack,
making it lasting longer, affecting headache frequency and
duration [21, 22] quality of life, health care expenditures
[23] and chronification [9]. In a Brazilian population, we
found anxiety subthreshold and full DSM diagnosis
(GAD) predominantly affecting migraine risk, generalized
anxiety disorder (GAD) with [OR (CI 95%)] 7.0 (4.2–11.7)
for all primary headaches, 7.8 (4.3–14.1) for migraine, 12.8
(4.5–36.3) for chronic migraine, and 3.9 (1.3–11.9) for
tension-type headache. Subthreshold anxiety showed
significantly higher ORs; whereas depression disclosed
lower ORs, 2.5 (1.5–3.9) for all headaches; 3.4 (2.0–5.7)
migraine; 3.8 (1.8–8.3) chronic migraine, and 1.1 (0.4–3.7)
for tension-type headache. These numbers supported the
ideia that anxiety plays a more important role than
depression in migraine risk. Moreover, the concept of a
subthreshold diagnosis, (where patients fit all but one item
for the full diagnostic criteria), being more linked to mi-
graine than GAD diagnosis and depression, are reinforced
by the findings in this study [23].
When we compare severe symptoms (e.g. when the
aspect or symptom is felt every day), much higher odds
are observed, particularly in anxiety, ranging from 24.4
to 49.2. “Not being able to stop or control worrying”
(OR 49.2), “trouble relaxing” (25.9), “Feeling nervous,
anxious or on edge” (25.4), “worrying too much about dif-
ferent things” (24.4) (Table 2). This “dose-response” ob-
served by us is unique and displays that some subsets of
patients with anxiety and depression display a much
higher risk than what has been reported by other popula-
tional studies [24, 25]. It is noteworthy that not only
excessive worry or tension, but the inability to control
them was found to be more important. Sheftell and Atlas
[26] mentioned losing the locus of control was a tipping
point in migraine chronification.
The implication of not controling anxiety on a daily
basis, as well as not easily relaxing, feeling anxious and ex-
perience daily excess in worrying should be better evalu-
ated in migraineurs in both population and clinic settings.
Not only in patients with a subthreshold, subclinical, par-
tial, or subsyndromal psychiatric diagnosis, terms used
synonymously to refer a clinical syndrome that does not
fully meet the DSM or ICD diagnosis; but also in patients
where those aspects can be found isolated, and should be
taken in consideration in migraine management. The
higher patients scored in the GAD-7 scale, the higher
the severity of anxiety, and patients scoring higher
than 7 (0–21) have shown a high sensitivity and specificity
[27] for the GAD diagnosis. The item “Not being able to
stop or control worrying” might be a good screening ques-
tion to assess anxiety implication in migraine.
Detecting anxiety symptoms and implementing pharma-
cological and non-pharmacological treatments targeting
those patterns could improve headache control and
patients’ quality of life. Psychoterapies with cognitive-
Fig. 1 Odds ratios for migraine risk according to anxiety (left) and depression (right) symptoms
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behavioural approach as well as physical and mental
relaxation techniques may be usefull add on therapeutic
strategies for migraine prevention. Although this has to be
specifically tested in clinical trials, improvement in anxiety
control is possibly the mechanism why behavioural
treatments are efficacious in migraine treatment. The
mechanisms behind the effect of preventive medications,
antidepressants and/or neuromodulators, could be by im-
proving anxiety-related abnormal physiological responses.
It is important to further understand the mechanisms
behind the lack of control in anxiety, excess worry, and
fear. Anxiety and fear-avoidance mechanisms have been
linked to several pain disorders including primary head-
aches [22]. One may hypothesize a probable role of genet-
ics, life events, psychological trauma, sleep, and cultural
aspects.
Excess worry, fear, and other anxiety symptoms can be
part of the migraine clinical spectrum. Irritability has
been recognized as part of the prodrome [28], muscle
tension a common finding in migraine and other head-
aches [29]. On the other hand, head pain may also be
part of an anxiety clinical spectrum. A relevant discus-
sion is whethere anxiety symptoms are part of the mi-
graine spectrum, or vice-versa, and if their comorbidity
is uni or bi-directional. As Merikangas first showed in
1990 and others confirmed [25], anxiety preceded
migraine diagnosis, therefore early recognizing and treat-
ment of anxiety symptoms in children and adolescentes
may reduce the appearance of migraine in the future.
Depression
The hallmark features of depression are emotional
symptoms, hopelessness and sadness; nevertheless, the
three highest scores found in our data were appetite,
fatigue, and sleep disturbances, all physical symptoms.
Although not possible to define whether increase or
decrease in appetite was occurring, we can suppose it
was increase, based on epidemiological data in depres-
sive disorders [30], and literature studying migraine and
obesity [31]. Decrease in appetite may also be present,
since nausea or vomiting are migraine symptoms. Our
findings support a common biological mechanism
between migraine and depression, through the hypothal-
amus, since it plays an important role in apetite, fatigue
and sleep function. A hypothalamic dysfunction can be
hypothesized as a link between both conditions.
The most related depression symptoms found: appetite,
fatigue, and poor sleep may be overemphasized in mi-
graine patients because they can be part of the migraine
clinical picture [32, 33]. In addition, lack of concentration
is commonly part of the migraine attack and is found
interictally [34]. It is unlikely a migraine patient, at least
near an attack, present without fatigue, apetite change,
sleep problems, lack of concentration, or lack of pleasure.
Feeling sad, although obviously expected during pain, was
found to be less common, as low self-esteem and death
thinking. One may speculate how valid and specific is de-
pression diagnosis in migraine patients, simply applying
DSM criteria and scales may not define the disorder, a
reappraisal of both epidemiological and clinical data re-
garding depression and migraine comorbidity is necessary,
previously published numbers could be affected by
depression physical symptoms and migraine features, as
well as case definitions, since studies varied accross DSM
III, IV and V.
A diary study could answer how these overlapping
symptoms are linked in headache disorders and psychi-
atric comorbidity, moreover, looking back into databases
and subtracting anxiety and depression symptoms may
help understanding the role of psychiatric symptoms in
migraine.
Another key aspect is irritability, a symptom of the
anxiety GAD-7 scale, but eventually more linked to
depression than anxiety, particularly if we consider it as
part of the bipolar spectrum. Becoming easily annoyed
or irritable had an OR 3.8 (1.9–7.8) if experienced some
days, 7.5 (2.7–20.7) more than half the days, and 22.0
(5.7–84.9) when experienced nearly every day. Irritability
is also part of the Attention Deficit Hyperactivity Dis-
order clinical spectrum. ADHD overlap with anxiety
clinical aspects, and can be a differential diagnosis. Four
out of seven GAD items may be related to ADHD:
trouble relaxing; feeling nervous, anxious or on edge;
becoming easily annoyed or irritable; being so restless
that is hard to sit still. ADHD is linked to the inability
or lack of control [35].
Our paper supports the validity symptom-based
concept, a relatively recent trend in mental health
research and medicine [36]. By dissecting different
elements in the two main disorder groups, anxiety
and depression, and looking at their ranges, from
mild to extreme manifestation, resulting in a more
detailed, deeper understanding of psychiatric comor-
bidity with migraine.
Although inverting the traditional paradigm of starting
with symptoms and moving towards a diagnosis, ask in-
vestigators to step back from pre-defined syndromes and
focus on basic dimensions of functioning could be an
important move in migraine comorbity research.
Strengths of our study are the robust sample size,
comprehensive general population studied, not only a
small set of young adults as seen in some seminal studies
in the area (breslau and merikangas), migraine diagnosis
were not self reported. Anxiety and depression were stud-
ied using detailed questionnaires, where sensitivity and
specificity for a DSM diagnosis has been validated [27].
Limitations include its cross-sectional study design,
where results are correlative and cannot address
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causality; absence of a full psychiatric diagnostic inter-
view, where other mental health issues relevant to mi-
graine comorbidity could be explore such as
psychological trauma, ADHD, and the bipolar
spectrum. The self-report nature of responses could
be a limitation but most of the data on comorbidity
was based on self-administered questionnaires.
Analyzing individual items from scales may be not
considered as good practice because it lacks the reliabil-
ity of the full scale, but this is the very concept we are
challenging here. Anxiety and depression symptoms are
overlapping and should be considered as a continuum
spectrum of affective symptoms, especially in presence
of pain disorders. Our objective was not to detect a psy-
chiatric disease but understand within the aspects raised
in each scale’s question, which are the most related to
migraine, we think this is what our paper adds to the
literature.
For further research, other psychiatric disorders, psy-
chological and cultural aspects, beliefs, personality, and
biological variables, from genetics to neuroimaging should
be studied, as implications in public health and treatment
outcomes. Studying other pain syndromes, other headache
disorders, migraine subtypes, migraine chronicity, other
chronic conditions, and their relation to anxiety and de-
pression symptoms would improve our understanding in
the field.
Conclusion
Anxiety overall and its symptoms had a stronger
association with migraine than depression. Hability to
control worrying and relaxing are the most prominent
issues in migraine psychiatric comorbidity. Physical
symptoms in depression are more linked to migraine
than emotional. A symptom-based approach helps
clarifying migraine comorbidity and should be repli-
cated in other studies.
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